Alternatives
Alternatives to SnagRx
SnagRx scores 81/100 on our Cost-Efficiency Index . Here are other programs to consider, each scored the same way. Partners are listed first.
SnagRx at a glance
- Semaglutide
- $99/moMonth-to-month, same price at every dose ($89 on a 3-month plan, $79 on 6 months, $69 on 12 months)
- Tirzepatide
- $149/moMonth-to-month, same price at every dose ($139 on a 3-month plan, $129 on 6 months, $119 on 12 months)
- Coverage
- All states except Louisiana (Nebraska: 19 and older)
- Brand-name GLP-1s
- No, compounded only
- Oral option
- No
- Pricing verified
- October 2026
1 of the 8 programs below lists semaglutide for less than SnagRx's $99 a month. 1 of the 8 lists tirzepatide for less than its $149 a month.
SnagRx sells compounded semaglutide at $99 and tirzepatide at $149 a month, the same at every dose, with lower rates on longer plans, four named compounding pharmacies, and service everywhere but Louisiana.
Best for: Budget shoppers who want a low flat price and a named compounding pharmacy, and who are comfortable with a strict refund policy.
What SnagRx does well
- Low flat month-to-month prices that don't rise with the dose, with no membership fee
- Names four specific, checkable compounding pharmacy partners
- Serves every state except Louisiana
- Displays a LegitScript seal that links to LegitScript's own checker
Why readers look for an alternative
- The homepage's $69 and $119 "sale" prices are the 12-month rates, shown against a struck-through $299 and $349; month to month it's $99 and $149
- All sales are final, and multi-month plans are non-refundable in whole and in part
- Medical director exists but is not named
- Not available in Louisiana; Nebraska patients must be 19 or older
- Partner01A94/ 100Index
CoreAge Rx
CoreAge Rx charges one flat price at every dose, $99 a month for semaglutide and $149 for tirzepatide, with no membership fee.
- Sema
- $99/mo
- Tirz
- $149/mo
- Coverage
- All 50 states
- Brand
- Compounded
- 02B−82/ 100Index
REMEVi
REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.
- Sema
- $199 per 4 weeksMonth-to-month, same at every dose; $159 per 4 weeks on a 24-week plan paid up front, compounded
- Tirz
- $269 per 4 weeksMonth-to-month, same at every dose; $225 per 4 weeks on a 24-week plan paid up front, compounded
- Coverage
- 49 states + DC
- Brand
- Compounded
Compared with SnagRx: $100/mo more for semaglutide · $120/mo more for tirzepatide · offers an oral option
- 03B−82/ 100Index
Jyra Health
Jyra Health’s monthly compounded injection plans cost $169 for semaglutide or $229 for tirzepatide at any dose. Lower advertised rates require prepayment, and its FAQ names three pharmacy partners.
- Sema
- $169/moAll doses, monthly compounded plan
- Tirz
- $229/moAll doses, monthly compounded plan
- Coverage
- All 50 states
- Brand
- Compounded
Compared with SnagRx: $70/mo more for semaglutide · $80/mo more for tirzepatide
- 04B−82/ 100Index
Good Life Meds
Good Life Meds is a direct-to-consumer telehealth platform selling compounded semaglutide and tirzepatide, plus name-brand Wegovy, the Wegovy pill, Ozempic, Zepbound and Mounjaro, as an all-inclusive per-order charge with no separate visit or membership fee.
- Sema
- $199/moAll doses, compounded
- Tirz
- $297/moAll doses, compounded
- Coverage
- All 50 states
- Brand
- Yes
Compared with SnagRx: $100/mo more for semaglutide · $148/mo more for tirzepatide · also lists brand-name GLP-1s · offers an oral option
- 05B−82/ 100Index
TeleZen MD
TeleZen MD offers compounded GLP-1 plans at $168 semaglutide and $268 tirzepatide monthly. Quarterly plans cost $297 and $597 upfront, with physician care, medication and shipping included.
- Sema
- $168/moAll doses, monthly plan, compounded; quarterly $297 upfront
- Tirz
- $268/moAll doses, monthly plan, compounded; quarterly $597 upfront
- Coverage
- Multi-state
- Brand
- Yes
Compared with SnagRx: $69/mo more for semaglutide · $119/mo more for tirzepatide · also lists brand-name GLP-1s
- 06B−81/ 100Index
Vytora Health
Vytora Health (Wasef Health, PC) is a 50-state-plus-DC telehealth platform selling flat-rate compounded semaglutide and tirzepatide alongside retail-priced brand-name Mounjaro and Zepbound ($1,399/mo each).
- Sema
- $179/moSame price at every dose, month to month, compounded, all-inclusive; $149/mo on a 3-month plan billed $447
- Tirz
- $249/moSame price at every dose, month to month, compounded, all-inclusive; $199/mo on a 3-month plan billed $599
- Coverage
- All 50 states
- Brand
- Yes
Compared with SnagRx: $80/mo more for semaglutide · $100/mo more for tirzepatide · also lists brand-name GLP-1s
- 07B−81/ 100Index
NuuVim
NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.
- Sema
- $79/moAll doses, 3-mo plan, new patients only, compounded
- Tirz
- $133/moAll doses, 3-mo plan, new patients only, compounded
- Coverage
- Multi-state
- Brand
- Yes
Compared with SnagRx: $20/mo less for semaglutide · $16/mo less for tirzepatide · also lists brand-name GLP-1s · offers an oral option
- 08B−81/ 100Index
Tyde Wellness
Tyde Wellness is a compounded-GLP-1 and longevity telehealth platform (weight loss, HRT, hair, longevity) serving all 50 states, with month-to-month semaglutide from $179/mo and tirzepatide from $249/mo, and lower rates on 3- and 6-month plans.
- Sema
- $179/moMicrodose tier, month to month, same price at every dose, compounded; full dose $249/mo; as low as $75/mo microdose on a 6-month plan paid up front
- Tirz
- $249/moMicrodose tier, month to month, same price at every dose, compounded; full dose $349/mo; as low as $92/mo microdose on a 6-month plan paid up front
- Coverage
- All 50 states
- Brand
- Compounded
Compared with SnagRx: $80/mo more for semaglutide · $100/mo more for tirzepatide
Assume any provider we list may compensate us — it never changes the Cost-Efficiency Index. Pricing and coverage reflect public disclosures at last review; confirm on each provider's site. Not medical advice. See our disclosure.